Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph early_phase_1
2
100%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
2(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (100.0%)

Trials by Status

not_yet_recruiting2100%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruitingearly_phase_1

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

NCT06986434
not_yet_recruitingearly_phase_1

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

NCT07077330

Clinical Trials (2)

Showing 2 of 2 trials
NCT06986434Early Phase 1

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Not Yet Recruiting
NCT07077330Early Phase 1

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Not Yet Recruiting

All 2 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
2